New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

Published Jun 1, 2020

New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

A new drug combination has been approved by the FDA for the treatment of lung cancer. This marks a historic development in research, but an expert says there's still more to be done

NOW
PLAYING
Glioblastoma Still Lethal Years After Deaths of McCain and Kennedy
NOW
PLAYING
FDA: Robotically-Assisted Surgical (RAS) Devices Not Authorized for Breast Cancer
NOW
PLAYING
COVID Booster Shots Approved for Cancer Patients, Other Immunocompromised Americans; No Prescription, ID is Required
NOW
PLAYING
NFL Coach Ron Rivera Beat Cancer With A Remarkable New Therapy -- His Advice For Survivors & What Got Him Through His Toughest Moments
NOW
PLAYING
Non-Smokers Take Note: Kathy Griffin is Part of the 20% of Lung Cancer Patients Who Have Never Smoked; What You Need to Know
NOW
PLAYING
It’s World Lung Cancer Day: How Have Treatment Options Changed for Lung Cancer Patients?

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.